Search results for "Melanoma Vaccine"

showing 3 items of 3 documents

Evaluation of genetic melanoma vaccines in cdk4-mutant mice provides evidence for immunological tolerance against authochthonous melanomas in the skin

2005

We evaluated the efficacy of a candidate melanoma vaccine approach in mice genetically prone to develop melanoma due to the introduction of an oncogenic mutation (R24C) in the germline sequence of the cyclin-dependent kinase 4 (cdk4), a protein critically involved in cell cycle regulation. Melanomas were induced in cdk4-mutant mice by chemical carcinogenesis and UVB irradiation. A genetic prime-boost strategy targeting the clinically relevant differentiation antigen tyrosinase-related protein 2 (TRP2) was performed which was able to stimulate a melanocyte-specific cellular immune response associated with localized autoimmune vitiligo-like depigmentation. However, significant destruction of …

Cancer ResearchSkin NeoplasmsUltraviolet Raysmedicine.medical_treatmentCancer VaccinesMelanoma VaccineDNA vaccinationMiceImmune systemDepigmentationAntigenImmune TolerancemedicineAnimalsGenetic Predisposition to DiseaseMelanomaneoplasmsGerm-Line MutationMice Knockoutbusiness.industryMelanomaCell CycleCyclin-Dependent Kinase 4Neoplasms ExperimentalImmunotherapymedicine.diseaseIntramolecular OxidoreductasesMice Inbred C57BLDisease Models AnimalOncologyImmunologyCarcinogensSkin cancermedicine.symptombusinessInternational Journal of Cancer
researchProduct

Dendritic cell-based immunotherapy of malignant melanoma: success and limitations.

2007

Dendritic cells (DC) are professional antigen-presenting cells in the immune system which are able to induce primary T-cell responses. Because of their central role in the initiation of immune responses, DC are an important tool for tumor-antigen-specific immunotherapy of cancer. DC vaccination using tumor-antigen-loaded DC has led to tumor regression in individual advanced-stage cancer patients. However, there is a discrepancy between strong and antigen-specific T cell responses in vaccinated cancer patients detectable ex vivo and only weak clinical responses. In most cases the immune system of advanced stage IV cancer patients allows only a temporary anti-tumor response and increasing evi…

Skin NeoplasmsEffectorT cellmedicine.medical_treatmentMelanomaModels ImmunologicalCancerDermatologyImmunotherapyDendritic cellDendritic CellsBiologymedicine.diseaseImmunotherapy AdoptiveMelanoma Vaccinemedicine.anatomical_structureImmune systemTreatment OutcomeImmunologyPractice Guidelines as TopicmedicineHumansPractice Patterns Physicians'MelanomaJournal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
researchProduct

Altered intracellular sorting signals do not influence the efficacy of genetic melanoma vaccines incorporating helper determinants in mice.

2004

Background A genetic melanoma vaccine consisting of cDNA encoding the model self-antigen tyrosinase-related protein 2 (TRP2) fused in-frame to the immunogenic enhanced green fluorescent protein (EGFP) was able to break immune tolerance and stimulate CD8+ T cells in vivo. In the present study we investigated whether alteration of the intracellular antigen localization as a result of the linkage with immune-enhancing helper proteins affects the resulting immune response. Methods Expression plasmids and recombinant adenoviruses were constructed encoding various fusion proteins with different intracellular sorting signals which direct the antigen to the cytosol, the endoplasmic reticulum or the…

Skin Neoplasmsmedicine.medical_treatmentRecombinant Fusion ProteinsGenetic VectorsGreen Fluorescent ProteinsMelanoma ExperimentalAutoimmunityBiologyCancer VaccinesMelanoma VaccineImmune toleranceMiceImmune systemAntigenDrug DiscoveryGeneticsmedicineAnimalsMolecular BiologyGenetics (clinical)MelanomaELISPOTImmunotherapyGenetic TherapyT-Lymphocytes Helper-Inducermedicine.diseaseMolecular biologyFusion proteinCell biologyIntramolecular OxidoreductasesMice Inbred C57BLProtein TransportCD4 AntigensMolecular MedicineImmunizationThe journal of gene medicine
researchProduct